EQL Pharma AB (publ) (STO:EQL)
Sweden · Delayed Price · Currency is SEK 59.10
-2.40 (-3.90%)
At close: Oct 10, 2025
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 1.75 billion as of October 10, 2025. Its market cap has increased by 12.87% in one year.
Market Cap
1.75B
Enterprise Value
2.14B
Revenue
397.94M
Ranking
n/a
PE Ratio
41.89
Stock Price
59.10
Market Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 1.75B, an increase of 2,131.08%. That is a compound annual growth rate of 30.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 1.75B | -25.87% |
| Dec 30, 2024 | 2.35B | 142.51% |
| Dec 29, 2023 | 970.72M | 16.78% |
| Dec 30, 2022 | 831.22M | -26.29% |
| Dec 30, 2021 | 1.13B | -2.27% |
| Dec 30, 2020 | 1.15B | 207.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 105.55B |
| Sectra AB | 58.76B |
| Getinge AB | 57.22B |
| Camurus AB | 41.49B |
| Medicover AB | 39.71B |
| Asker Healthcare Group AB | 33.44B |
| BioArctic AB | 26.56B |
| AddLife AB | 22.67B |